Literature DB >> 18470280

Focal therapy for prostate cancer.

Danil V Makarov1, Alan W Partin.   

Abstract

Entities:  

Year:  2008        PMID： 18470280      PMCID： PMC2312349     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  10 in total

1.  Cancer incidence and mortality in Europe, 2004.

Authors:  P Boyle; J Ferlay
Journal:  Ann Oncol       Date:  2005-02-17       Impact factor: 32.976

2.  Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

Authors:  David C Miller; Stephen B Gruber; Brent K Hollenbeck; James E Montie; John T Wei
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

3.  Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.

Authors:  B M Gburek; T A Kollmorgen; J Qian; S M D'Souza-Gburek; M M Lieber; R B Jenkins
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

Review 4.  How good is MRI at detecting and characterising cancer within the prostate?

Authors:  Alexander P S Kirkham; Mark Emberton; Clare Allen
Journal:  Eur Urol       Date:  2006-06-30       Impact factor: 20.096

5.  Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.

Authors:  Christopher R King; John E McNeal; Harcharan Gill; Joseph C Presti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

6.  Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens.

Authors:  Alphaeus M Wise; Thomas A Stamey; John E McNeal; John L Clayton
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

7.  Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.

Authors:  Stacy Loeb; Chris M Gonzalez; Kimberly A Roehl; Misop Han; Jo Ann V Antenor; Ronald L Yap; William J Catalona
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

8.  Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.

Authors:  Charles D Scales; Joseph C Presti; Christopher J Kane; Martha K Terris; William J Aronson; Christopher L Amling; Stephen J Freedland
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

Review 9.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Authors:  Scott E Eggener; Peter T Scardino; Peter R Carroll; Michael J Zelefsky; Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Samson W Fine; John Trachtenberg; Mark A Rubin; Mak Ohori; Kentaro Kuroiwa; Michel Rossignol; Lucien Abenhaim
Journal:  J Urol       Date:  2007-10-15       Impact factor: 7.450

10.  The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Authors:  Matthew R Cooperberg; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
  10 in total
  1 in total

1.  Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates.

Authors:  Olga Starobinets; Richard Guo; Jeffry P Simko; Kyle Kuchinsky; John Kurhanewicz; Peter R Carroll; Kirsten L Greene; Susan M Noworolski
Journal:  J Magn Reson Imaging       Date:  2013-10-17       Impact factor: 4.813
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.